People With Xylazine Wounds Face Barriers to Seeking Wound Care
By Lori Solomon HealthDay Reporter
THURSDAY, Aug. 29, 2024 -- People with self-identified xylazine wounds are more likely to engage in subcutaneous injection and face several barriers to seeking medical wound treatment, according to a study published online Aug. 21 in Drug and Alcohol Dependence.
Raagini Jawa, from the University of Pittsburgh School of Medicine, and colleagues sought to understand drug use and wound care practices and treatment experiences of people who use drugs (PWUD). The analysis included 171 survey responses from PWUD.
The researchers found that 87 percent had a xylazine wound in the past 90 days. There were no significant demographic differences between those with and without xylazine wounds. Among respondents primarily injecting (155 people), subcutaneous injection was nearly 10 times more likely among those with xylazine wounds (148 people). Of people with xylazine wounds, wound self-treatment practices were heterogeneous. Among those with xylazine wounds, when seeking medical care, 74 percent experienced health care stigma and 58 percent had inadequate pain and withdrawal management.
"Programs serving people exposed to xylazine should work to support safer injection practices, including alternatives to injecting and improving access to high-quality, effective wound care," the authors write. "Further study is warranted to understand the causes, promoters, and prevention of xylazine-related wounds."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted August 2024
Read this next
Gene Therapy Effective in Patients With Recessive Dystrophic Epidermolysis Bullosa
WEDNESDAY, June 25, 2025 -- For patients with recessive dystrophic epidermolysis bullosa (RDEB), a one-time surgical application of prademagene zamikeracel, an autologous COL7A1...
Most People With Cannabis Use Disorder Remain Untreated
MONDAY, June 9, 2025 -- Most individuals in the United States with cannabis use disorder (CUD) do not receive treatment, according to a study published online May 19...
2021 to 2023 Saw Rise in Cannabis Use by Older Adults
THURSDAY, June 5, 2025 -- From 2021 to 2023, the prevalence of current cannabis use increased among older U.S. adults, according to a research letter published online June 2...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.